Send Enquiry

GENVIMAX
Tablets
Packaging and packing Type
Blister | 10x15
MRP :
₹79
PTR :
₹60.19
PTS :
₹54.17
Prescription medicine Read More
Composition
Send Enquiry
Available on PCD franchise with monopoly rights: Ortho PCD franchise
India’s Trusted Pharma Brand
100%
Genuine Products
Secure
Payments
24 x 7
Customer Support
About the product
By Vibcare Pharma · Updated 9 October 2026 · Based on product labels and standard drug references
Salzovib 500 DR Tablets contain Sulfasalazine Delayed Release 500 mg, a disease-modifying antirheumatic drug (DMARD) and bowel anti-inflammatory agent, supplied in a delayed-release tablet form. The product is packed as 10x15 (Blister) and comes from Vibcare Pharma's Genvimax division.
The delayed-release design keeps the tablet intact in the stomach and lets it release the medicine further down in the intestine. There, sulfasalazine is split into 5-aminosalicylic acid, which works on the inflamed lining of the colon, and sulfapyridine, which helps to settle inflammation in the joints. This split action is what makes the ingredient useful both for bowel disease and for joint disease.
Salzovib 500 DR is used for mild to moderate ulcerative colitis, for keeping ulcerative colitis in remission, and for rheumatoid arthritis.
Use only on a doctor's prescription, at the dose and for the duration advised.
Common
Get medical help at once if you notice
Do not use
Ask a doctor first
For distributors and medical representatives
Salzovib 500 DR Tablet is part of Vibcare Pharma's ortho range. Take the range to your area as a PCD franchise partner, with monopoly rights in your district.
Salzovib 500 DR is a delayed-release sulfasalazine 500 mg tablet used for ulcerative colitis and rheumatoid arthritis. Main uses: treatment of mild to moderate ulcerative colitis; maintenance of remission in ulcerative colitis; mild to moderate Crohn's disease involving the colon (colonic Crohn's disease); rheumatoid arthritis as a disease-modifying agent (DMARD).
Common side effects of Salzovib 500 DR Tablet include nausea and vomiting; stomach pain or discomfort; loss of appetite; headache; skin rash or itching; feeling unwell or tired. Get medical help at once if you notice blood disorders such as fall in white cells, red cells or platelets; severe skin reactions with blisters or peeling; liver inflammation or jaundice.
Each Salzovib 500 DR tablet contains Sulfasalazine Delayed Release 500 mg. The right dose and how long to take it depend on the condition, age and other medicines, so use Salzovib 500 DR Tablet only as your doctor advises.
The MRP of Salzovib 500 DR Tablet is ₹79 for a pack of 10x15 (Blister). For chemists and distributors, the PTR is ₹60.19 and the PTS is ₹54.17.
Each Salzovib 500 DR tablet contains Sulfasalazine Delayed Release 500 mg. It comes in a pack of 10x15 (Blister).
The delayed-release design keeps the tablet intact in the stomach and lets it release the medicine further down in the intestine. There, sulfasalazine is split into 5-aminosalicylic acid, which works on the inflamed lining of the colon, and sulfapyridine, which helps to settle inflammation in the joints. This split action is what makes the ingredient useful both for bowel disease and for joint disease.
Must not be used by patients allergic to sulfasalazine, sulfonamides or salicylates (aspirin-like drugs). Must not be used in children under 2 years of age. Must not be used in patients with intestinal or urinary obstruction, or with porphyria. Must not be used in patients with severe liver or kidney disease or with serious blood disorders. Check with a doctor first if you have asthma, are pregnant, or are breastfeeding; baseline and regular blood count, liver function and kidney function tests are recommended during treatment.
Salzovib 500 DR Tablet is a brand of Vibcare Pharma, sold through its Genvimax division. It is available for PCD pharma franchise and distribution in India; use the Send Enquiry or WhatsApp button on this page to ask about availability and terms.
Send Enquiry
Request a callback to get more information about becoming a PCD Franchise Owner